Ecolab (ECL)

The Service-and-Formulation Model

Ecolab files the cleanest evidence of pricing power among large specialty chemical companies. It sells water treatment, hygiene and infection-prevention programmes: chemistry delivered with a service. FY2025 organic sales at fixed currency grew 3%, made of +1% volume and +2% value pricing, Ecolab's term for its price increases. Gross margin rose 100 bps to 44.5% from 43.5% in FY2024, and the 10-K credits value pricing for the gain.

Service and lease sales were 21.5% of FY2025 net sales, the rest product and equipment. The service is why a hotel, hospital or food plant rarely switches supplier: the chemicals are a small share of its costs, and the service that doses and monitors them is what it is buying. Prices can therefore rise while volumes still grow. The specialty versus commodity guide sets out that distinction.

The pattern held earlier too: in Q1 2024 organic sales grew 5%, with pricing contributing 3 points. The pricing power guide uses Ecolab's FY2025 bridge as its full-year example.

How the Numbers Read

EBITDA margin is derived from the 10-K: $3,765M of EBITDA, with no adjustments, divided by $16,081M of net sales, gives 23.4%. That is above the coatings companies, whose adjusted margins are in the high teens. Net debt of $7,590M at 31 December 2025 was 2.0 times that EBITDA.

Ecolab's rise in gross margin, beside a positive price line, is stronger evidence that costs are being passed on than the 30 bps rises at Sherwin-Williams and IFF. Gross margins at services and coatings businesses usually move less than 100 bps a year, so Ecolab's rise sits at the top of that range. A move above 200 bps points to commodity prices or inventory effects, as in Albemarle's swing of more than ten points between FY2024 and FY2025.

Valuation Framework

The first method question for any specialty business is whether its filings show costs passed on: organic growth with a positive price line, and a gross margin that holds. Where they do, a stable margin carried through a DCF fits, with an industry multiple on normalised earnings as a cross-check. The premium valuation guide covers which multiples to use.

Ecolab's earnings come from recurring contracts with hotels, hospitals and food plants, not from the gap between a selling price and a feedstock cost. Its gross margin sits between Sherwin-Williams' 48.8% and PPG's 41.3%, and all three raised prices in FY2025.

What to Watch in the Financials

The organic bridge. Recompute the volume and price split each quarter; a price contribution that shrinks while input costs rise would be an early sign that pass-through is slipping.

Gross margin against input costs. Tie margin moves to raw-material, energy and freight costs.

EBITDA definition. Ecolab's EBITDA margin is derived and unadjusted. Label it when setting it beside PPG's segment EBITDA margin (19.3%) or Sherwin-Williams' adjusted 19.6%.

Key Risks

Institutional demand. Volume moves with restaurant, hotel and hospital activity. Pricing power does not protect Ecolab from a fall in customers' own business, and FY2025 volume growth was already thin.

Cost inflation outrunning price. Pass-through comes as value pricing, often with a lag. A period when costs rise faster than prices would show first in gross margin, then in the bridge.